Status:

COMPLETED

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)

Lead Sponsor:

French National Agency for Research on AIDS and Viral Hepatitis

Collaborating Sponsors:

Hoffmann-La Roche

Gilead Sciences

Conditions:

Leukoencephalopathy, Progressive Multifocal

HIV Infections

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Progressive multifocal leucoencephalopathy (PML) is a rare infectious disease of the brain, provoked by the JC virus. It usually occurs in subjects with impaired immune system as during HIV infection....

Detailed Description

The aim of this open-label multicentre study is to estimate the effect of an early therapy intensification based on potent antiretroviral combination including enfuvirtide(FUZEON®) on survival in pati...

Eligibility Criteria

Inclusion

  • 18 years of age and older
  • Have confirmed laboratory diagnosis of HIV infection
  • Presenting with a clinical history of active PML evolving (or continuing to deteriorate) for less than 90 days
  • Diagnosis of PML documented for less than 30 days at the inclusion by cerebral imaging (MRI) AND the absence of another demonstrated etiology AND the detection of JCV DNA in the CSF by qualitative PCR.
  • Signed written inform consent

Exclusion

  • Concomitant opportunistic infection of the central nervous system
  • Pregnancy, breast-feeding
  • Co-infection by the HIV2
  • History of immunotherapy including interleukin-2 and alpha-interferon
  • History of treatment by FUZEON® or by cidofovir
  • Contra-indication to receive FUZEON

Key Trial Info

Start Date :

April 1 2005

Trial Type :

INTERVENTIONAL

End Date :

December 1 2007

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00120367

Start Date

April 1 2005

End Date

December 1 2007

Last Update

December 22 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Service de Medecine interne et Maladies Infectieuses, Hopital Bicetre

Le Kremlin-Bicêtre, France, 94270